BILL ANALYSIS                                                                                                                                                                                                    







                      SENATE COMMITTEE ON PUBLIC SAFETY
                           Senator Gloria Romero, Chair              A
                             2007-2008 Regular Session               B

                                                                     1
                                                                     1
                                                                     4
          AB 1141 (Anderson)                                         1
          As Amended January 7, 2008 
          Hearing date:  June 24, 2008
          Health and Safety Code
          JM:br

                                 CONTROLLED SUBSTANCES

                             KHAT, CATHINONE AND CATHINE  

                                       HISTORY

          Source:  San Diego District Attorney

          Prior Legislation: None directly on point

          Support: United States Postal Inspector; Federal Bureau of  
                   Investigation; San Diego County Sheriff; California  
                   Narcotic Officers' Association; California District  
                   Attorneys Association; Riverside Sheriffs' Association;  
                   Association for Los Angeles Deputy Sheriffs;  
                   Sheriff-Coroner of San Bernardino County; Los Angeles  
                   County District Attorney

          Opposition:None known

          Assembly Floor Vote:  Ayes 76 - Noes 0


                                       KEY ISSUE
           
          SHOULD KHAT (ANY PART OF THE PLANT CATHA EDULIS) AND CATHINONE  
          BE PLACED IN SCHEDULE II OF THE CONTROLLED SUBSTANCE SCHEDULES?




                                                                     (More)







                                                         AB 1141 (Anderson)
                                                                      PageB


          SHOULD CATHINE BE PLACED IN SCHEDULE IV OF THE CONTROLLED  
          SUBSTANCE SCHEDULES?

                                                                (CONTINUED)



          SHOULD POSSESSION OF KHAT, CATHINONE OR CATHINE BE A MISDEMEANOR?

          WITHOUT THE NECESSITY OF PROVING THAT THESE SUBSTANCES ARE ANALOGS  
          OF AMPHETAMINE, A SCHEDULED DRUG, SHOULD POSSESSION FOR SALE OF  
          KHAT, CATHINE OR CATHINONE BE A FELONY, WITH A PRISON TERM OF 16  
          MONTHS, TWO YEARS OR THREE YEARS?

          SHOULD SALE OF KHAT, CATHINE OR CATHINONE BE A FELONY, WITH A PRISON  
          TERM OF TWO YEARS, THREE YEARS OR FOUR YEARS?


                                       PURPOSE

          The purposes of this bill are to:  1) place khat (parts of the  
          plant Catha Edulis) and cathinone in Schedule II of the  
          controlled substances schedules, thereby making commerce in each  
          substance a felony; 2) place cathine in Schedule IV, thereby  
          making commerce in this substance a felony; 3) provide that  
          possession of khat, cathine or cathinone is a misdemeanor; and  
          4) allow defendants to be directly prosecuted for crimes  
          involving these substances, rather than requiring proof that the  
          substances are analogs of amphetamine in order for prosecutor's  
          to obtain convictions.
          
           Existing law  classifies controlled substances in five schedules  
          according to their danger and potential for abuse.  Schedule I  
          controlled substances have the greatest restrictions and  
          penalties, and are deemed by law to have no accepted medical  
          use.  (Health and Saf. Code  11054-11058.)

           Existing federal law  (21 U.S.C.  812) includes the following  
          scheduling criteria  :  




                                                                     (More)







                                                         AB 1141 (Anderson)
                                                                      PageC


                 Schedule I:  The drug or other substance has a high  
               potential for abuse.  The drug or other substance has  
               no currently accepted medical use in treatment in the  
               United States.  There is a lack of accepted safety for  
               use of the drug or other substance under medical  
               supervision.

                 Schedule II:  The drug or other substance has a  
               high potential for abuse.  The drug or other substance  
               has a currently accepted medical use in treatment in  
               the United States or a currently accepted medical use  
               with severe restrictions.  Abuse of the drug or other  
               substances may lead to severe psychological or  
               physical dependence.


                 Schedule III:  The drug or other substance has a  
               potential for abuse less than the drugs or other  
               substances in Schedules I and II.  The drug or other  
               substance has a currently accepted medical use in  
               treatment in the United States.  Abuse of the drug or  
               other substance may lead to moderate or low physical  
               dependence or high psychological dependence.

                 Schedule IV.  The drug or other substance has a low  
               potential for abuse relative to the drugs or other  
               substances in Schedule III.  The drug or other  
               substance has a currently accepted medical use in  
               treatment in the United States.  Abuse of the drug or  
               other substance may lead to limited physical  
               dependence or psychological dependence relative to the  
               drugs or other substances in Schedule III.

                 Schedule V:  The drug or other substance has a low  
               potential for abuse relative to the drugs or other  
               substances in Schedule IV.  The drug or other  
               substance has a currently accepted medical use in  
               treatment in the United States.  Abuse of the drug or  
               other substance may lead to limited physical  




                                                                     (More)







                                                         AB 1141 (Anderson)
                                                                      PageD

               dependence or psychological dependence relative to the  
               drugs or other substances in Schedule IV.

           Existing California law  does not include a list of criteria  
          for scheduling controlled substances.  California law  
          schedules are generally consistent with federal schedules.   
          (Health & Saf. Code  11054-11058.)

           Existing law  provides that an analog of a scheduled controlled  
          substance shall be treated the same as the scheduled substance  
          for purposes of prosecution and punishment other than being  
          under the influence of the analog.  An analog is defined as a  
          substance with similar chemical properties or effects to  
          another substance.  (Health and Saf. Code  11400-11401.)

           Existing law  provides that possession of a Schedule II or IV  
          stimulant is an alternate felony-misdemeanor, punishable by a  
          county jail term of up to one year, a fine of up to $1,000, or  
          both, or by a prison term of 16 months, 2 years or 3 years and a  
          fine of up to $10,000.  (Health & Saf. Code  11377.)

           Existing law  provides that possession for sale of any Schedule  
          II or IV stimulant is a felony, with a prison term of 16 months,  
          2 years or 3 years and a fine of up to $10,000.  (Health & Saf.  
          Code  11378, subd. (a).)

           Existing law  provides that sale, furnishing, et cetera, any  
          Schedule II or IV stimulant is a felony, with a prison term of  
          2, 3 or 4 years and a fine of up to $10,000.

           Existing federal law and regulations  classify cathinone as a  
          Schedule I stimulant unless specifically excepted or unless  
          listed in another schedule, any material, compound, mixture, or  
          preparation which contains any quantity of the following  
          substances having a stimulant effect on the central nervous  
          system, including its salts, isomers, and salts of isomers.  (21  
          U.S.C.  812; 21 Code of Fed. Regs.  1308.11 (f)(3).)


           Existing federal law and regulations  classify cathine as a  




                                                                     (More)







                                                         AB 1141 (Anderson)
                                                                      PageE

          Schedule IV stimulant unless specifically excepted or unless  
          listed in another schedule, any material, compound, mixture,  
          or preparation which contains any quantity of the following  
          substances having a stimulant effect on the central nervous  
          system, including its salts, isomers and salts of isomers.   
          (21 U.S.C.  812; 21 Code of Fed. Regs.  1308.14 (e)(1).)

           Existing law  provides that sale of ephedrine to minors is a  
          misdemeanor.  (Health & Saf. Code  110423.2.)

           Existing law  provides that any sale of any product containing  
          ephedrine must include a warning as to adverse effects of the  
          drug.  (Health & Saf. Code  110423.)
          
           This bill  provides that any material, compound, mixture, or  
          preparation which contains any quantity of khat, which includes  
          all parts of the plant classified botanically as Catha Edulis,  
          whether growing or not, the seeds thereof, any extract from any  
          part of the plant, and every compound, manufacture, salt,  
          derivative, mixture, or preparation of the plant, its seeds, or  
          extracts having a stimulant effect on the central nervous  
          system is a controlled substance listed in Schedule II.

           This bill states that any material, compound, mixture, or  
          preparation which contains any quantity of cathinone having a  
          stimulant effect on the central nervous system is a controlled  
          substance listed in Schedule II.

           This bill  provides that any material, compound, mixture, or  
          preparation which contains any quantity of cathine having a  
          stimulant effect on the central nervous system, including its  
          salts, isomers (whether optical, position, or geometric), and  
          salts of those isomers is possible within the specific chemical  
          designation is a controlled substance listed in Schedule II.

           This bill  creates a misdemeanor for the unlawful possession of  
          khat, cathinone, or cathine punishable by up to one year in  
          county jail.

           This bill makes the possession for sale of khat and cathinone  




                                                                     (More)







                                                         AB 1141 (Anderson)
                                                                      PageF

          for the purpose the sale a felony punishable by 16 months, 2  
          years or 3 years in state prison.

           This bill  creates a felony for the transportation and sale of  
          khat and cathinone, punishable by 2, 3, or 4 years in state  
          prison.

              RECEIVERSHIP/OVERCROWDING CRISIS AGGRAVATION IMPLICATIONS
          
          California continues to face an extraordinary and severe prison  
          and jail overcrowding crisis.  California's prison capacity  
          remains nearly exhausted as prisons today continue to be  
          operated with a significant level of overcrowding.<1>  A year  
          ago, the Legislative Analyst's office summarized the trajectory  
          of California's inmate population over the last two decades:

              During the past 20 years, jail and prison  
              populations have increased significantly.  County  
              jail populations have increased by about 66  
              percent over that period, an amount that has been  
              limited by court-ordered population caps.  The  
              prison population has grown even more dramatically  
              during that period, tripling since the  
              mid-1980s.<2>

          The level of overcrowding, and the impact of the population  
          crisis on the day-to-day prison operations, is staggering:

              As of December 31, 2006, the California Department  
              of Corrections and Rehabilitation (CDCR) was  
              estimated to have 173,100 inmates in the state  
              prison system, based on CDCR's fall 2006  
              population projections.  However, . . . the  
              department only operates or contracts for a total  
              of 156,500 permanent bed capacity (not including  
              --------------------
          <1>  Analysis of the 2007-08 Budget Bill:  Judicial and Criminal  
          Justice, Legislative Analyst's Office (February 21, 2007); see  
          also, court orders, infra.
          <2>  California's Criminal Justice System:  A Primer.   
          Legislative Analyst's Office (January 2007).



                                                                     (More)







                                                         AB 1141 (Anderson)
                                                                      PageG

              out-of-state beds, . . . ), resulting in a  
              shortfall of about 16,600 prison beds relative to  
              the inmate population.  The most significant bed  
              shortfalls are for Level I, II, and IV inmates, as  
              well as at reception centers.  As a result of the  
              bed deficits, CDCR houses about 10 percent of the  
              inmate population in temporary beds, such as in  
              dayrooms and gyms.  In addition, many inmates are  
              housed in facilities designed for different  
              security levels.  For example, there are currently  
              about 6,000 high security (Level IV) inmates  
              housed in beds designed for Level III inmates.

              . . .  (S)ignificant overcrowding has both  
              operational and fiscal consequences.  Overcrowding  
              and the use of temporary beds create security  
              concerns, particularly for medium- and  
              high-security inmates.  Gyms and dayrooms are not  
              designed to provide security coverage as well as  
              in permanent housing units, and overcrowding can  
              contribute to inmate unrest, disturbances, and  
              assaults.  This can result in additional state  
              costs for medical treatment, workers'  
              compensation, and staff overtime.  In addition,  
              overcrowding can limit the ability of prisons to  
              provide rehabilitative, health care, and other  
              types of programs because prisons were not  
              designed with sufficient space to provide these  
              services to the increased population.  The  
              difficulty in providing inmate programs and  
              services is exacerbated by the use of program  
              space to house inmates.  Also, to the extent that  
              inmate unrest is caused by overcrowding,  
              rehabilitation programs and other services can be  
              disrupted by the resulting lockdowns.<3>

          As a result of numerous lawsuits, the state has entered into  
          several consent decrees agreeing to improve conditions in the  
          state's prisons.  As these cases have continued over the past  


          ---------------------------
          <3>  Analysis 2007-08 Budget Bill, supra, fn. 1.



                                                                     (More)







                                                         AB 1141 (Anderson)
                                                                      PageH

          several years, prison conditions nonetheless have failed to  
          improve and, over the last year, the scrutiny of the federal  
          courts over California's prisons has intensified.

          The federal court has appointed a receiver to take over the  
          direct management and operation of the prison medical health  
          care delivery system from the state.  The crisis has continued  
          to escalate and, in July of last year, the federal court  
          established a three-judge panel to consider placing a cap on the  
          number of prisoners allowable in California prisons.  It is  
          anticipated that the court will reach its decision this year.

          In his order establishing the judicial panel, Judge Thelton  
          Henderson stated in part:

            It is clear to the Court that the crowded conditions  
            of California's prisons, which are now packed well  
            beyond their intended capacity, are having - and in  
            the absence of any intervening remedial action, will  
            continue to have - a serious impact on the Receiver's  
            ability to complete the job for which he was  
            appointed:  namely, to eliminate the unconstitutional  
            conditions surrounding delivery of inmate medical  
            health care.

            . . .  (T)his case is also somewhat unique in that even  
            Defendants acknowledge the seriousness of the  
            overcrowding problem, which led the Governor to declare  
            a state of emergency in California's prisons in October  
            2006.  While there remains dispute over whether crowded  
            conditions are the primary cause of the constitutional  
            problems with the medical health care system in  
            California prisons, or whether any relief other than a  
            prisoner release order will remedy the constitutional  
            deprivations in this case, there can be no dispute that  
            overcrowding is at least part of the problem.  . . .   
            The record is equally clear that the Receiver will be  
            unable to eliminate the constitutional deficiencies at  
            issue in this case in a reasonable amount of time  
            unless something is done to address the crowded  




                                                                     (More)







                                                         AB 1141 (Anderson)
                                                                      PageI

            conditions in California's prisons.  This Court  
            therefore believes that a three-judge court should  
            consider whether a prisoner release order is warranted  
            . . . .  (Hon. Thelton Henderson, Order dated July 23,  
            2007 in Plata v. Schwarzenegger (N.D. Cal) No. C01-1351  
            TEH (citations omitted).)

          Similarly, Judge Lawrence Karlton stated:

            There is no dispute that prisons in California are  
            seriously and dangerously overcrowded.  ()  The  
            record suggests there will be no appreciable change  
            in the prison population in the next two years.   
            (Hon. Lawrence K. Karlton, Senior Judge, United  
            States District Court, Order dated July 23, 2007 in  
            Coleman v. Schwarzenegger (E.D. Cal.) No. S90-0520  
            LKK JFM P (citations omitted).)

           This bill  does not appear to aggravate the prison overcrowding  
          crisis outlined above.

                                      COMMENTS

          1.  Need for This Bill  

          According to the author:

            AB 1141 is a clean-up measure to help in the  
            prosecution of khat drug cases.  Conforming California  
            law to federal policy in this area is an important  
            crime-fighting tool that will bring the full force of  
            the law against the growing numbers of those who  
            traffic in this dangerous substance.

          2.  Prosecutions of Defendants for Conduct Involving Unscheduled  
            Drugs through Proof the Drug is an Analog of a Scheduled  
            Drug  

          As noted in "Existing law," above, California law specifically  
          provides that a person can be prosecuted for drug crimes if  




                                                                     (More)







                                                         AB 1141 (Anderson)
                                                                      PageJ

          the drug involved in the charged act is an "analog" of a  
          specifically scheduled controlled substance, regardless that  
          the actual substance is not specifically scheduled.  (Health  
          and Saf. Code  11401.)

          The sponsor has informed Committee counsel that persons who  
          possess khat or engage in khat commerce can be prosecuted under  
          the California analog statute.  In particular, the prosecution  
          proves that khat is an analog of amphetamine, a drug  
          specifically listed in Schedule II of the controlled substance  
          schedules.  However, counsel has been unable to find any  
          published cases considering khat prosecutions brought under the  
          analog statute.

          Prosecutions using the analog statute are more expensive and  
          time-consuming than other drug prosecutions.  The prosecution  
          must establish that a drug is an analog of a scheduled drug  
          through testimony of an expert chemist and the jury must find  
          that fact true beyond a reasonable doubt.

          AS PERSONS CAN BE PROSECUTED FOR KHAT CRIMES UNDER THE EXISTING  
          DRUG ANALOG STATUTE, IS THIS BILL NECESSARY?

          3.  Background on Khat:  Origin, History, Effects, Use and  
          Derivative Chemicals  

          The New York State Office of Alcohol and Substance Abuse  
          Services collects and produces research and educational material  
          about drugs.  The office has published the following discussion  
          of khat:



            Khat (Catha edulis, family Celastraceae), pronounced  
            "cot" and also known as qat, gat, chat, and miraa, is a  
            flowering plant native to tropical East Africa.   
            Believed to originate in Ethiopia, it is a shrub or  
            small tree, with evergreen leaves, growing to 5-8  
            meters tall.  The flowers grow on short stems and each  
            flower has 5 white petals.  The fruit is oblong and  




                                                                     (More)







                                                         AB 1141 (Anderson)
                                                                      PageK

            contains 1-3 seeds.



            Khat has been grown for use as a stimulant for  
            centuries in the Horn of Africa and the Arabian  
            Peninsula.  There, chewing khat predates the use of  
            coffee and is used in a similar social context.  Its  
            fresh leaves and tops are chewed or, less frequently,  
            dried and consumed as tea, in order to achieve a state  
            of euphoria and stimulation.  Khat can also be smoked  
            or sprinkled on food. The stimulant effect is most  
            effective when the leaves are still fresh and within 48  
            hours of cutting the plant, khat will begin to lose its  
            potency (decrease in cathinone levels).



            Khat use has traditionally been confined to the regions  
            where khat is grown, because only the fresh leaves have  
            the desired stimulating effects.  In recent years  
            improved roads, off-road motor vehicles and air  
            transport have increased the global distribution of  
            this perishable commodity.  Traditionally, khat has  
            been used as a socializing drug, and this is still very  
            much the case in Yemen, where khat-chewing is a  
            predominantly male habit.  It is mainly a recreational  
            drug in the countries which grow khat, though it may  
            also be used by farmers and laborers for reducing  
            physical fatigue, and by drivers and students for  
            improving attention.  This is similar to the use of the  
            coca leaf in South America.



            Khat is used for its mild euphoric and stimulating  
            effects.  The stimulant effect of the plant was  
            originally attributed to cathine, a phenethylamine-type  
            substance isolated from the plant.  However, the  
            attribution was disputed by reports showing the plant  




                                                                     (More)







                                                         AB 1141 (Anderson)
                                                                      PageL

            extracts from fresh leaves contained another substance  
            more behaviorally active than cathine.



            In 1975, the related alkaloid, cathinone, was isolated,  
            and its absolute configuration was established in 1978.  
             Cathinone is not very stable and breaks down to  
            produce cathine and norephedrine.  These chemicals  
            belong to the PPA (phenylpropanolamine) family, a  
            subset of the phenethylamines related to amphetamines  
            and the catecholamines, epinephrine and norepinephrine.  
             PPA has been banned from over the counter cough and  
            cold preparations in the U.S.



            Khat consumption induces mild euphoria and excitement.   
            Individuals become very talkative under the influence  
            of the drug and may appear to be unrealistic and  
            emotionally unstable.  Khat can induce manic behaviors  
                                      and hyperactivity.  Several cases of khat-induced  
            psychosis have been reported in the literature.  Khat  
            is an effective anorectic and its use also results in  
            constipation.



            Dilated pupils (mydriasis), which are prominent during  
            khat consumption, reflect the sympathomimetic effects  
            of the drug, which are also reflected in increased  
            heart rate and blood pressure.  A state of drowsy  
            hallucinations (hypnagogic hallucinations) may result  
            as the drug effects wear off.  Withdrawal symptoms that  
            may follow prolonged khat use include lethargy, mild  
            depression, nightmares, and slight tremor.



            Cathine is in Schedule IV and cathinone is in Schedule  




                                                                     (More)







                                                         AB 1141 (Anderson)
                                                                      PageM

            I of the U.S. Controlled Substance Act.  The 1993 DEA  
            rule placing cathinone in Schedule I noted that it was  
            effectively also banning khat.


          4.  California has No Procedure or Resources for Determining How  
            Controlled Substances Should be Scheduled  

          As is noted in the "Purpose" section above, the function of the  
          controlled substance schedules is to classify drugs in regard to  
          risk of abuse in relation to medical benefit.  Schedule I drugs  
          are presumed to have no medical benefit and present great risk  
          of abuse.  Generally speaking, although exceptions abound,  
          penalties and restrictions for distribution or use diminish from  
          Schedule I through Schedule V.

          Arguably, scheduling decisions would best be done through expert  
          analysis and research.  However, there is no formal or informal  
          process to evaluate controlled substances in California.  
          Effectively, legislative committee staff members evaluate bills  
          proposing scheduling of a drug, read available research and  
          consider the arguments of lobbyists and interested parties.   
          Legislators then vote on scheduling bills.

          In contrast, the federal government uses an administrative  
          process for scheduling drugs.  The Drug Enforcement  
          Administration requests evaluation of a drug by the Department  
          of Health and Human Services.  HHS solicits information from the  
          Food and Drug Administration and the National Institute of Drug  
          Abuse and other experts.  HHS compiles the information and  
          submits it to the DEA with a recommendation concerning  
          scheduling.

          DOES CALIFORNIA EFFECTIVELY HAVE NO PROCESS FOR EXPERT  
          EVALUATION FOR PURPOSES OF SCHEDULING CONTROLLED SUBSTANCES?

          5.  Different Effects and Abuse Potential for Khat, Cathine and  
            Cathinone; Cultural Considerations  

          Khat generally means the leaves of the Catha Edulis plant.  In  




                                                                     (More)







                                                         AB 1141 (Anderson)
                                                                      PageN

          the Middle East and East Africa, khat has been used for  
          centuries in social settings to stimulate interaction and  
          conversation.  It appears that drugs isolated from the plant are  
          not commonly used in areas where khat is grown and where use of  
          khat is part of the culture.  This bill could be criticized as  
          targeting persons of Middle Eastern descent, particularly  
          Muslims.  People from the Middle East are likely to chew khat  
          leaves.  Users of khat may argue that it is no more dangerous  
          than alcohol, especially when used in controlled social  
          settings.

          This author and sponsor, perhaps recognizing these cultural  
          issues, have drafted this bill to provide that simple possession  
          of khat, cathinone or cathine is a misdemeanor.  Possession of  
          amphetamine - an analog of khat - is an alternate  
          felony/misdemeanor.  Under existing law, a person in possession  
          of an analog of a scheduled drug can be prosecuted as though the  
          person possessed the scheduled drug.  That is, a person in  
          possession of khat can effectively be prosecuted for possession  
          of amphetamine under existing law.  (The sponsor has informed  
          the Committee that khat prosecutions have been successfully  
          maintained under the analog statute.  Committee counsel has been  
          unable to find any appellate cases on this issue.)

          Drug researchers at Virginia Commonwealth University have  
          likened the development of drugs isolated from Khat to the  
          development of cocaine from the coca plant.  Indigenous people  
          in South America have chewed coca leaves and brewed coca tea for  
          hundreds of years.  It appears that such use of coca is  
          relatively benign.  Cocaine hydrochloride is produced from coca  
          through a chemical process.  Cocaine is a powerful drug that has  
          become a widespread drug of abuse.












                                                                     (More)











          Similarly, cathinone is an amphetamine-like stimulant that is  
          produced from khat or synthesized.  (A person chewing khat does  
          ingest cathinone, but in relatively slowly absorbed and limited  
          amounts.)  An analog of cathinone, called methcathinone, is  
          stronger than cathinone.  Cathinone and methcathinone are much  
          more likely to produce serious harm to users than the use of  
          khat in social settings.

          The chemical name of cathine is norpseudoephedrine.<4>   
          Norpseudoephedrine is a regulated chemical in California.   
          Strict reporting requirements apply to commerce in the  
          chemical.  Possession of norpseudoephedrine and with intent to  
          manufacture methamphetamine is a felony.  (Health & Saf. Code   
          11383.5.)  Cathine is a stimulant, but it appears to be  
          significantly less powerful than cathinone.  The effects of  
          cathine have been compared to ephedrine, which has been a  
          common ingredient in nasal decongestant products and so-called  
          nutritional supplement and diet aids.  It appears that  
          ephedrine is a regulated chemical.  As a regulated chemical,  
          strict reporting requirements are required for commerce in the  
          chemical.  Any sale of a product containing ephedrine must  
          include a warning of possible negative effects from the drug.   
          (Health & Saf. Code  110423.)  It is a misdemeanor to sell  
          ephedrine to a minor.  (Health & Saf. Code  110423.2.)

          A review of the scientific research indicates that khat leaves  
          fairly rapidly lose potency, especially as concerns the amount  
          of cathinone ingested by the user.  It has been estimated that  
          khat contains only cathine, and no cathinone, after about 48  
          hours in an un-refrigerated state.  Khat imported into the  
          United States is likely to be significantly less potent than  
          fresh khat used in the Middle East.  This perhaps indicates that  
          khat possession, possession for sale and sale should be treated  
          substantially less harshly than such acts involving cathinone in  
          isolated or synthesized forms.
          ---------------------------
          <4>  All of these drugs and chemicals have numerous isomers with  
          slight variations in molecular structure.  This bill  
          specifically places "(+) norpseudoephedrine" (cathine) in  
          Schedule IV.



                                                                     (More)







                                                         AB 1141 (Anderson)
                                                                      PageP


          However, the sponsor has noted that fresh khat is imported into  
          the U.S. through air express services.  The use of air express  
          service allows importation of khat leaves that are still fully  
          potent.  The sponsor also notes reports of khat being cultivated  
          in Riverside County.

          The New York Office of Substance Abuse, in a "Street Advisory"  
          memo stated the following about khat use:

            Fresh khat leaves, which are typically chewed like  
            tobacco, produce a mild cocaine- or amphetamine-like  
            euphoria that is much less potent than either substance  
            with no reports of a rush sensation or paranoia  
            indicated.  By filling the mouth to capacity with fresh  
            leaves the user then chews intermittently to release  
            the active components.  Chewing khat leaves produces a  
            strong aroma and generates intense thirst.  Casual  
            users claim khat lifts spirits, sharpens thinking, and,  
            when its effects wear off, generates mild lapses of  
            depression similar to those observed among cocaine  
            users.

          This bill punishes the possession, possession for sale, and sale  
          of khat, cathine and cathinone the same.  Arguably, the  
          penalties for khat should not be as serious as those for cathine  
          and cathinone, particularly cathinone.  

          AS CATHINE APPEARS TO HAVE EFFECTS THAT ARE SIMILAR TO EPHEDRINE  
          (A LEGAL DRUG THAT CANNOT BE SOLD TO MINORS) SHOULD CATHINE BE  
          AN ILLEGAL SUBSTANCE?

          SHOULD POSSESSION OF KHAT, CATHINE OR CATHINONE BE A  
          MISDEMEANOR?

          SHOULD POSSESSION FOR SALE OF THESE SUBSTANCES BE A FELONY, WITH  
          A PRISON TRIAD OF 16 MONTHS, 2 YEARS OR 3 YEARS?

          SHOULD SALE OF THESE SUBSTANCES BE A FELONY, WITH A PRISON TRIAD  
          OF 2, 3 OR 4 YEARS?












                                                         AB 1141 (Anderson)
                                                                      PageQ


          DOES THE MAKING OF POSSESSION OF KHAT A MISDEMEANOR, AND  
          COMMERCE IN KHAT A FELONY, INDICATE A CULTURAL BIAS AGAINST  
          PEOPLE OF MIDDLE EASTERN DESCENT?



                                   ***************